Cetaphil® Skin Care Products
March 2017: This action was dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed.
September 2016: A false advertising class-action lawsuit was filed against Galderma Laboratories in September 2016 (and transferred to federal court in October 2016) for allegedly misleadingly representing that Cetaphil® skin care products treat or mitigate eczema when, in reality, they do not. (Greenberg et al v. Galderma Laboratories, L.P. and Does 1-100, Case No. 16-cv-6090, N. D. CA.)
Class-Action Tracker
The Latest
New York City is Taking on Shady Subscriptions
And TINA.org is all for it.
What You Should Know about Kalshi
Prediction market faces legal challenges on multiple fronts.
NJ tax dollars spent on ‘Blue Ribbon’ school awards that critics call deceptive
Julie O’Connor, NJ Spotlight News
The Regulatory Loopholes Behind Prevagen’s Rise
Sara Talpos, Med Shadow
CATrends: Tequilas Marketed as 100% Agave
Ingredient claims come into the limelight.